• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·HCTI
Share

Healthcare Triangle, Inc. Stocks

$ 1.74Last Updated 14.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 2.05M

$ 1.74
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and streamline digital transformation. Among its proprietary software offerings are CloudEz, an enterprise platform streamlining multi-cloud migration and oversight, allowing clients to unify management of their private, hybrid, and public cloud environments. Another key platform is DataEz, a cloud-native solution providing robust data analytics and scientific data processing capabilities tailored for the life sciences, pharmaceutical, and healthcare provider sectors. Additionally, the company offers Readabl.AI, a Software-as-a-Service (SaaS) solution leveraging public cloud-based artificial intelligence and machine learning to intelligently identify and extract vital healthcare data from diverse documents such as faxes and narrative reports. Beyond its platforms, Healthcare Triangle delivers a range of cloud-centric IT services and specialized healthcare IT support. This includes the implementation, optimization, and integration of electronic health records (EHR) systems with community partners, comprehensive application managed services, and reliable public cloud-based backup and disaster recovery solutions. Its diverse client base spans healthcare providers, insurance carriers, pharmaceutical and life sciences firms, biotechnology companies, and medical device manufacturers. Established in 2019, Healthcare Triangle, Inc. operates out of Pleasanton, California, as a subsidiary of SecureKloud Technologies, Inc.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

16.07.2026 10:30

Morning Roundup: New Strikes on Iran, Anthropic Heads Toward an IPO, and a Sell-Off in Asia

16.07.2026 09:30

"Market Leaders Face a Test of Resilience": Goldman Explains How to Protect Your Portfolio

16.07.2026 08:30

United Warned of $6 Billion in Additional Fuel Costs. Why the Profit Forecast Was Raised

16.07.2026 07:30

UBS recommends buying SpaceX shares ahead of a new rocket test. The shares have fallen 33% from their peak.

16.07.2026 03:25

Apple Is on the Hunt for AI Chip Makers — The Information

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026